USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/34455
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFrunze, Cristian-
dc.contributor.authorCiobanu, Natalia-
dc.date.accessioned2026-10-30T12:50:28Z-
dc.date.accessioned2026-11-17T12:50:05Z-
dc.date.available2026-10-30T12:50:28Z-
dc.date.available2026-11-17T12:50:05Z-
dc.date.issued2026-
dc.identifier.citationFrunze, Cristian; Ciobanu, Natalia. COMPARATIVE STUDY OF CARDIOEMBOLIC AND NON-CARDIOEMBOLIC STROKE PATIENTS. In: MedEspera 2026, p. 640. ISBN 978-9975-82-486-6.en_US
dc.identifier.isbn978-9975-82-486-6-
dc.identifier.urihttps://medespera.md/documents/abstract-book-4.pdf-
dc.identifier.urihttps://repository.usmf.md/handle/20.500.12710/34455-
dc.descriptionUniversitatea de Stat de Medicină și Farmacie „Nicolae Testemițanu”, Chișinău, Republica Moldovaen_US
dc.description.abstractIntroduction. Stroke represents the leading cause of disability among the working-age population in the Republic of Moldova. At the European level, The Stroke Action Plan for Europe (SAP -E) highlights the underutilization of oral anticoagulants for stroke prevention in patients with atrial fibrillation (AF). Aim of study. Comparing demographic and clinical characteristics between cardioembolic stroke patients and the rest of the stroke cohort. Methods and materials. A retrospective observational cohort study was conducted on 287 patients diagnosed with acute stroke, admitted during two distinct periods: January-April 2024 and July 2025. Anamnestic, clinical, and paraclinical data were collected from the medical records. The NIHSS (National Institutes of Health Stroke Scale) score was used to assess the severity of neurological deficit at admission, and the CHA2DS2-VA score was calculated to evaluate the cardioembolic risk in these patients. Results. The study consisted of 287 patients admitted with acute stroke. Cardioembolic stroke etiology was established in 117 patients (40.8%). AF was identified as the leading cause of cardioembolic stroke, accounting for 86.3% of the cases. The prevalence of hypertension(84.6%), ischemic heart disease (23.9%) and congestive heart failure (17.95%) in the studied cohort reflects a complex cardiovascular profile. Patients with cardioembolic stroke were significantly older, with a mean age of 72.4 years (±9.87), with the mean age of the entire cohort, which was 68.6 years (±10.5). Moreover, the severity of neurological deficits at the time of stroke onset was also more pronounced, as reflected by a mean NIHSS score of 11.6 in the cardioembolic group, compared to 9.7 in the entire cohort, suggesting larger infarct volumes consistent with cardiac embolism. The mean CHA2DS2-VA score was 3.97 (±1.6), indicating a moderate-to-high cardiovascular risk profile in the studied population. Regarding topography, the ischemic lesions were more commonly found in the middle cerebral artery (MCA) territory, accounting for 67.5%. At admission, the majority of the cardioembolic stroke subgroup, or 49.6%, whereas 24.8% were receiving heparins, and 4.3% were receiving vitamin K antagonists. Importantly, 10.3% received no anticoagulation despite evident embolic risk. Overall in-hospital mortality was 18.1%, with 74.6% discharged home. Conclusions. Stroke is a major cause of death and disability, with AF playing a central role in cardioembolic etiology (86.3% of cases). Cardioembolic patients were older, had more severe neurological deficits, and predominant MCA involvement. Hypertension (84.6%), ischemic heart disease (23.9%), and heart failure (17.9%) contributed to the cardiovascular risk profile. These findings support systematic AF screening and integrated prevention strategies.en_US
dc.publisherCentrul Editorial-Poligrafic Medicinaen_US
dc.relation.ispartofMedEspera 2026. The 11th International Medical Congress for Students and Young Doctors, 6-8 May 2026en_US
dc.subjectcardioembolic strokeen_US
dc.subjectatrial fibrillationen_US
dc.subjecthypertensionen_US
dc.subjectNIHSSen_US
dc.subjectCHA2DS2-VAen_US
dc.subjectanticoagulationen_US
dc.titleCOMPARATIVE STUDY OF CARDIOEMBOLIC AND NON-CARDIOEMBOLIC STROKE PATIENTSen_US
dc.typeArticleen_US
Appears in Collections:MedEspera 2026

Files in This Item:
File Description SizeFormat 
M_640.pdf447.4 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback